Skip to main content
K

Kunshan Kersen Science & Technology Co.,Ltd — Investor Relations & Filings

Ticker · 603626 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2026-04-22 Audit Report / Informat…
Country CN China
Listing Shanghai Stock Exchange 603626

About Kunshan Kersen Science & Technology Co.,Ltd

Kunshan Kersen Science & Technology Co., Ltd. specializes in the research, development, design, and manufacturing of precision structural components. The company provides comprehensive solutions for precision metal and plastic parts, utilizing advanced technologies such as CNC machining, precision stamping, die-casting, and sophisticated surface treatments. Its product portfolio includes structural frames, internal components, and aesthetic parts for a diverse range of applications. Key target markets encompass the consumer electronics sector, including smartphones, tablets, and wearable devices, as well as the medical equipment and new energy vehicle industries. By integrating design innovation with high-precision manufacturing processes, the company delivers customized components that meet stringent technical requirements for global clients.

Recent filings

Filing Released Lang Actions
2025年非经营性资金占用及其他关联资金往来情况
Audit Report / Information Classification · 1% confidence The document is a standalone specialized audit report issued by China Audit Asia Pacific Certified Public Accountants LLP on the company’s non-operational fund occupation and related party fund transactions for fiscal year 2025. It contains an auditor’s opinion, audit scope, and detailed tables of related party fund movements, which are characteristic of an Audit Report rather than an Annual Report or mere announcement. Therefore, it should be classified as AR (Audit Report / Information).
2026-04-22 Chinese
关于2026年度“提质增效重回报”行动方案的公告
Regulatory Filings Classification · 1% confidence The document is a standalone corporate announcement by the board outlining a 2026 “quality improvement, efficiency increase and shareholder return” action plan. It is not an annual or interim financial report, earnings release, dividend notice, proxy statement, share issue or buyback, audit report, or board change notice. It does not simply announce the publication of a report but provides substantive content on strategy, governance, R&D and investor return measures. No specific specialized category applies, so it falls under the general regulatory announcement/fallback category.
2026-04-22 Chinese
关于召开2025年年度股东会的通知
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of the 2025 annual general shareholders’ meeting, including the meeting agenda, voting methods, registration procedures, proposal details, and an attached proxy form. It is not the minutes or results of the meeting, nor a full annual or interim financial report. Rather, it is distributed to shareholders to inform them of the meeting and solicit their votes via proxies. Hence, it matches the Proxy Solicitation & Information Statement category.
2026-04-22 Chinese
2025年度独立董事述职报告（袁秀国）
Governance Information Classification · 1% confidence The document is a formal annual work report by an independent director (“独立董事述职报告”), detailing board meetings attendance, committee activities, governance processes, internal controls, and compliance with corporate governance rules. It is not announcing board changes or simple meeting results, nor is it a financial report (10-K/IR/ER), call transcript, or proxy solicitation. This type of report relates to the company’s governance practices and board structure. Therefore it best fits the Governance Information category (CGR).
2026-04-22 Chinese
2025年年度报告
Regulatory Filings
2026-04-22 Chinese
关于2025年度日常关联交易执行情况暨2026年度日常关联交易预计的公告
Regulatory Filings Classification · 1% confidence The document is an official announcement by the company disclosing its 2025 related‐party transactions executed and the estimated 2026 related‐party transactions, including detailed tables and corporate approvals. It is a routine regulatory disclosure under Chinese securities listing rules rather than a full annual or interim report, earnings release, management discussion & analysis, or any financing/corporate action. It does not fall into specialized categories like share issues, dividends, M&A or board changes. Therefore it is best classified as a general regulatory filing (RNS).
2026-04-22 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.